pennystockhaven
  • Facebook
  • Twitter
  • Youtube
  • Rss
Day-Trading Penny Stocks
  • Home
  • Services
  • Contact Us
Home» Commentary » Former Wall Street Investment Banker Settles SEC Charges of Insider Trading

Former Wall Street Investment Banker Settles SEC Charges of Insider Trading

Posted on October 7, 2010 by PennyStockHaven in Commentary - No Comments

Litigation Release:

The Securities and Exchange Commission announced that on September 21, 2010, the Honorable Alvin K. Hellerstein of the United States District Court for the Southern District of New York entered a judgment of permanent injunction against Igor Poteroba, formerly an investment banker with UBS Securities LLC (“UBS”), who had been charged with insider trading for misappropriating highly confidential inside information from UBS about eleven impending acquisitions, tender offers, or other business combinations, and tipping a friend, also a financial professional, who traded securities on the basis of the tipped inside information. The insider trading yielded more than $1 million in illicit profits. The Court’s order permanently enjoins Poteroba from violating certain antifraud provisions of the federal securities laws. The judgment resolves only the Commission’s claims of liability against Poteroba. The Commission’s claims for disgorgement of illicit profits and a civil penalty against Poteroba will be ruled upon by the Court at a later date.

The Commission’s complaint, filed on March 24, 2010, alleged that, from at least July 2005 through February 2009, Poteroba participated in an insider trading ring that netted over $1 million in illicit profits. According to the complaint, Poteroba was the source of material, nonpublic information about eleven impending corporate transactions, which he obtained through his work as an investment banker in UBS’s Global Healthcare Group. Poteroba misappropriated the material, nonpublic information from his employer and its clients in breach of duties of confidentiality that he owed them. Pursuant to the insider trading scheme as described in the complaint, Poteroba tipped his friend, defendant Aleksey Koval, with the material nonpublic information, and Koval, in turn, tipped his friend, defendant Alexander Vorobiev. The Commission’s complaint alleges that both Koval and Vorobiev traded securities on the basis of the material, nonpublic information tipped to Koval by Poteroba.

Without admitting or denying the allegations in the complaint, Poteroba has consented to the entry of a judgment that permanently enjoins him from committing future violations Section 10(b) of the Securities Exchange Act of 1934 (“Exchange Act”) and Rule 10b-5 thereunder, which are antifraud provisions of the federal securities laws, and Section 14(e) of the Exchange Act and Rule 14e-3 thereunder, which are tender offer fraud provisions.

On September 28, 2010, the Commission issued an order pursuant to Section 15(b)(6) of the Exchange Act and Section 203(f) of the Investment Advisers Act of 1940 barring Poteroba from association with any broker, dealer, or investment adviser. Poteroba consented to the issuance of the order without admitting or denying the findings therein.

The Commission’s civil action against defendants Koval and Vorobiev, and relief defendants Tatiana Vorobieva and Anjali Walter, remains pending before the Court.

On July 26, 2010, the U.S. Attorney for the Southern District of New York filed a criminal information charging Poteroba with securities fraud and conspiracy to commit securities fraud.

 Source

Global Healthcare Group, insider trading

Search

Real Time Alerts:

Tweets by @PennyStockHaven

Updates

  • CVR Partners, LP (NYSE: UAN): the dividend play

    February 26, 2023
  • Sotera Health

    Sotera Health Company (NASDAQ:SHC): hard road ahead

    February 21, 2023
  • ZIM Integrated Shipping Services (NYSE:ZIM) uphill movement

    February 20, 2023
  • Carvana Co. (NYSE: CVNA) way to go… down

    February 17, 2023
  • ReWalk Robotics (RWLK): Yesterday, Today and Tomorrow

    June 8, 2019
  • Amyris, Inc. (AMRS): How to Mislead Investors

    April 21, 2019
  • ADMA Biologics, Inc. (ADMA): Offering is Imminent

    April 11, 2019
  • Proteostasis Therapeutics (PTI): Market Overreaction

    March 26, 2019
  • Dynagas LNG Partners LP (NYSE: DLNG) Coming Off Of Bottom

    February 1, 2019
  • Histogenics Corporation (HSGX) market: only upside from these levels

    September 5, 2018
  • Quantum Corp. (QTM): Appointed Jamie Lerner as Chief Executive Officer and President

    June 26, 2018
  • FuelCell Energy (NASDAQ:FCEL) A picture is worth a thousand words

    June 22, 2018

    Site

    • Home
    • Services
    • Contact Us
    • About Us
    • Privacy Policy
    • Terms of Use
    • Disclaimer
    • Publishers

    Financial Network

    Yahoo Finance
    Reuters
    The Motley Fool
    WSJ
    CNBC
    Business Week
    The Street
    Bloomberg

    psh sloganYour Everything Penny Stocks Resource



    Copyright © 2021 PennyStockHaven.com. All Rights Reserved